Related Experiment Videos
Preventive effect of vitamin C (L-ascorbic acid) on methylcholanthrene-induced soft tissue sarcomas in mice
Abstract:
The effect of vitamin C (L-ascorbic acid) on methylcholanthrene (MCA)-induced local malignant sarcomas in mice was investigated. Four groups of mice were given single intramuscular application of MCA at a dose level of 0.5 mg/0.1 ml olive oil for each animal. Doses of 6, 25, and 35 mg vitamin C (VC)/mouse were given to animals of groups B, C and D, respectively. VC was applied in drinking water by intragastric administration 5 times weekly for the first 20 weeks. Animals of group A served as carcinogenic controls. The application of VC statistically prevented the induction of sarcomas in mice of groups B, C and D compared to carcinogenic controls (group A). VC supplementation did not significantly reduce the diameters and weights of tumors. It was concluded that, under the experimental conditions conducted, VC significantly prevented the induction of sarcomas in mice providing a good prophylactic activity; however, it did not achieve a significant therapeutic level.
Insights
Vitamin C (ascorbic acid) demonstrated significant prophylactic activity by preventing methylcholanthrene-induced sarcomas in mice. However, it did not significantly reduce existing tumor size or weight, indicating limited therapeutic effect.
Area of Science:
- Oncology
- Biochemistry
- Cancer Research
Background:
- Methylcholanthrene (MCA) is a known carcinogen that induces local malignant sarcomas.
- Vitamin C (L-ascorbic acid) is an antioxidant with potential anti-cancer properties.
- Investigating prophylactic and therapeutic effects of Vitamin C in chemically induced cancers is crucial.
Purpose of the Study:
- To evaluate the effect of Vitamin C on the induction of MCA-induced sarcomas in mice.
- To assess both the preventative (prophylactic) and treatment (therapeutic) potential of Vitamin C.
Main Methods:
- Four groups of mice were administered MCA to induce sarcomas.
- Three groups received varying doses of Vitamin C (6, 25, 35 mg/mouse) via intragastric administration 5 times weekly for 20 weeks.
- One group served as carcinogenic controls without Vitamin C supplementation.
Main Results:
- Vitamin C statistically prevented the induction of sarcomas in mice across all tested doses compared to controls.
- No significant reduction was observed in tumor diameters or weights with Vitamin C supplementation.
- Vitamin C exhibited notable prophylactic activity against sarcoma development.
Conclusions:
- Vitamin C demonstrates significant prophylactic efficacy in preventing methylcholanthrene-induced sarcomas in mice.
- Vitamin C supplementation did not yield significant therapeutic benefits in reducing established tumor size or weight.
- Further research may explore optimal dosing or combination therapies for therapeutic applications.